Clinicaltrial.gov Website Gets a Facelift
(Thursday, December 9, 2021)
The clinicaltrials.gov website is undergoing modernization to be more user friendly and mobile optimized. The new website will evolve over the next year. It starts this week with a beta version which is an optional format for now as you can go back to the “classic” version. In a year’s time, the “classic” version will be retired. Clinicaltrials.gov is the world’s largest registry of clinical trials which still maintains a website that was designed almost two decades ago, way before smartphone existed. Hence, it is hard to use clinicaltrials.gov website on mobile platforms, the more preferred format for most users. Also, the organization of information on the website can use some upgrades. Keeping this is mind, the “keeper” of the website, NIH, along with the “overseer” of the content, FDA, put together a plan more than two years ago to update the website. The beta version is the first outcome of that plan. The modernization is based on catering to three categories of users of the website: (1) patients looking to participate in clinical trials, (2) researchers trying to learn from clinical trials in the registry, and (3) sponsors of clinical trials providing information about their trials. The website starts with two primary options, are you searching for clinical trials that are (1) looking for participants, or (2) have posted results. The first option is obviously targeted for patients, and the second to researchers. One can still search all studies as the classic site. Once you pick an option, the sub-options on the sidebar show relevant criteria. For sponsors of trials posting their trial info to the website, the updates allow easier posting of information with user friendly options. There are no changes in the information requirements for posters of clinical trials. This is just the start. NIH and FDA plan more upgrades based on the feedback from users. These upgrades are intended to maintain the dominance of the website as the source of worldwide clinical trial information.
Dr. Mukesh Kumar
Founder & CEO, FDAMap
Linkedin: Mukesh Kumar, PhD, RAC